Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Cell Metabolism
|
November 4, 2020
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh, Susy M Kim, Cyrielle Caussy, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2026
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA)
Veeral Ajmera, Raj Vuppalanchi, Mandana Khalili, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease
Cyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Hepatology (Baltimore, Md.)
|
December 9, 2014
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
Rohit Loomba, Claude B Sirlin, Brandon Ang, et al.
The Journal of Clinical Investigation
|
June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
Cyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
The Journal of Clinical Investigation
|
November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
Nobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Advances in Therapy
|
August 24, 2023
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Daniel Q Huang, Veeral Ajmera, Christian Tomaszewski, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease
Monica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, et al.
Alimentary Pharmacology & Therapeutics
|
April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
Suzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Cell Metabolism
|
November 4, 2020
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh, Susy M Kim, Cyrielle Caussy, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2026
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA)
Veeral Ajmera, Raj Vuppalanchi, Mandana Khalili, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease
Cyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Hepatology (Baltimore, Md.)
|
December 9, 2014
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
Rohit Loomba, Claude B Sirlin, Brandon Ang, et al.
The Journal of Clinical Investigation
|
June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
Cyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
The Journal of Clinical Investigation
|
November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
Nobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Advances in Therapy
|
August 24, 2023
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Daniel Q Huang, Veeral Ajmera, Christian Tomaszewski, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease
Monica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, et al.
Alimentary Pharmacology & Therapeutics
|
April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
Suzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Page
of 8